Guidance For Pharmacist Principal Investigator

Professionals

Pharmacists

1 October 2021

Guidelines for pharmacists seeking to become Principal Investigators in clinical trials, outlining eligibility requirements, responsibilities and regulatory compliance.

The Health Products (Clinical Trials) Regulations were amended on 1 October 2021 to allow registered pharmacists to be Pharmacist Investigators (PIs) of clinical trials. The guidance is intended to apply to clinical research involving locally registered products of lower risk profiles, including regulated clinical trials. The guidance provides information to Pharmacists regarding the requirements that would need to be fulfilled should they wish to become PIs such as education, training, experience, resources and responsibilities. In addition to what is stated in the document, for the purpose of being PIs on research grant applications, the pharmacist should also refer to any additional requirements/eligibility conditions that may be imposed by the funding agency.

Guidance for Pharmacists as Pharmacist Investigators [PDF, 142 KB]